2024 Q2 Form 10-Q Financial Statement

#000110448524000114 Filed on April 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $560.8M $396.3M $793.5M
YoY Change 17.67% -31.92% 114.24%
Cost Of Revenue $100.9M $156.7M $148.0M
YoY Change -16.98% 100.62% 33.93%
Gross Profit $459.9M $239.7M $645.6M
YoY Change 29.53% -52.45% 148.39%
Gross Profit Margin 82.01% 60.47% 81.35%
Selling, General & Admin $13.54M $193.0K $9.553M
YoY Change 9.16% -83.92% -56.25%
% of Gross Profit 2.94% 0.08% 1.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $176.6M $174.0M $151.2M
YoY Change 65.95% 83.85% 95.55%
% of Gross Profit 38.4% 72.58% 23.42%
Operating Expenses $192.4M $176.2M $161.5M
YoY Change 59.95% 81.96% 62.89%
Operating Profit $218.9M $63.52M $484.0M
YoY Change -6.75% -82.38% 201.12%
Interest Expense -$37.70M -$37.93M -$36.51M
YoY Change 17.92% -225.82% 48.51%
% of Operating Profit -17.22% -59.7% -7.54%
Other Income/Expense, Net -$37.63M $56.00K $83.00K
YoY Change -52368.06% -100.28%
Pretax Income $181.3M $14.45M $447.6M
YoY Change -12.34% -95.76% 208.61%
Income Tax $42.70M $2.846M $58.76M
% Of Pretax Income 23.55% 19.69% 13.13%
Net Earnings $138.6M $11.61M $388.9M
YoY Change -17.44% -96.59% 191.73%
Net Earnings / Revenue 24.71% 2.93% 49.0%
Basic Earnings Per Share $1.38 $0.12
Diluted Earnings Per Share $1.36 $0.11 $3.90
COMMON SHARES
Basic Shares Outstanding 101.1M shares 100.9M shares 100.5M shares
Diluted Shares Outstanding 102.0M shares 101.6M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.778M $32.47M $8.195M
YoY Change -47.46% 434.63% 224.17%
Cash & Equivalents $7.778M $32.47M $8.195M
Short-Term Investments
Other Short-Term Assets $43.91M $46.07M $127.4M
YoY Change -58.35% -60.1% 175.33%
Inventory
Prepaid Expenses
Receivables $359.6M $331.1M $370.5M
Other Receivables $2.335M $3.139M $3.249M
Total Short-Term Assets $413.7M $412.8M $509.4M
YoY Change 7.24% 4.26% 58.95%
LONG-TERM ASSETS
Property, Plant & Equipment $4.266B $4.205B $3.932B
YoY Change 32.62% 44.22% 58.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.11M $15.51M $15.47M
YoY Change -75.63% -5.95% -4.65%
Total Long-Term Assets $4.311B $4.221B $3.975B
YoY Change 31.47% 43.23% 55.59%
TOTAL ASSETS
Total Short-Term Assets $413.7M $412.8M $509.4M
Total Long-Term Assets $4.311B $4.221B $3.975B
Total Assets $4.725B $4.634B $4.484B
YoY Change 28.92% 38.62% 55.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $150.1M $156.2M $192.7M
YoY Change -2.52% 16.36% 49.84%
Accrued Expenses $215.8M $189.6M $147.9M
YoY Change 3.91% 16.96% 21.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $465.6M $428.0M $385.8M
YoY Change 22.92% 23.95% 11.82%
LONG-TERM LIABILITIES
Long-Term Debt $1.875B $1.939B $1.836B
YoY Change 12.1% 10.35% 20.33%
Other Long-Term Liabilities $2.509M $193.8M $2.741M
YoY Change -98.5% 6271.83% 34.03%
Total Long-Term Liabilities $2.509M $2.133B $2.741M
YoY Change -99.86% 70003.94% 34.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $465.6M $428.0M $385.8M
Total Long-Term Liabilities $2.509M $2.133B $2.741M
Total Liabilities $2.656B $2.632B $2.437B
YoY Change 18.12% 14.69% 14.4%
SHAREHOLDERS EQUITY
Retained Earnings $72.37M -$66.18M -$77.79M
YoY Change -114.69% -89.98% -92.23%
Common Stock $1.996B $2.068B $503.0K
YoY Change 4.58% 21.04% 3.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.068B $2.002B $2.048B
YoY Change
Total Liabilities & Shareholders Equity $4.725B $4.634B $4.484B
YoY Change 28.92% 38.62% 55.96%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $138.6M $11.61M $388.9M
YoY Change -17.44% -96.59% 191.73%
Depreciation, Depletion And Amortization $176.6M $174.0M $151.2M
YoY Change 65.95% 83.85% 95.55%
Cash From Operating Activities $340.5M $392.1M $342.3M
YoY Change 10.62% 45.61% 19.12%
INVESTING ACTIVITIES
Capital Expenditures $197.7M $407.1M $361.1M
YoY Change -46.95% -11.74% -31.84%
Acquisitions
YoY Change
Other Investing Activities -$25.50M -$17.09M
YoY Change -32.0% 17.88%
Cash From Investing Activities -$223.2M -$407.1M -$378.1M
YoY Change -45.58% -11.74% -30.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -142.0M 39.18M 30.99M
YoY Change -227.78% -79.95% -87.62%
NET CHANGE
Cash From Operating Activities 340.5M 392.1M 342.3M
Cash From Investing Activities -223.2M -407.1M -378.1M
Cash From Financing Activities -142.0M 39.18M 30.99M
Net Change In Cash -24.69M 24.27M -4.833M
YoY Change -382.72% 584.71% -26.79%
FREE CASH FLOW
Cash From Operating Activities $340.5M $392.1M $342.3M
Capital Expenditures $197.7M $407.1M $361.1M
Free Cash Flow $142.8M -$14.91M -$18.73M
YoY Change -320.09% -92.23% -92.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 nog Gain Loss On Contingent Consideration
GainLossOnContingentConsideration
0 usd
CY2023Q1 nog Gain Loss On Contingent Consideration
GainLossOnContingentConsideration
6176000 usd
CY2024Q1 nog Derivative Gain Loss On Derivative Commodity Contracts Net
DerivativeGainLossOnDerivativeCommodityContractsNet
-138531000 usd
CY2023Q1 nog Derivative Gain Loss On Derivative Commodity Contracts Net
DerivativeGainLossOnDerivativeCommodityContractsNet
153656000 usd
CY2024Q1 us-gaap Revenues
Revenues
396348000 usd
CY2023Q1 us-gaap Revenues
Revenues
582214000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
105447000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
78088000 usd
CY2024Q1 us-gaap Production Tax Expense
ProductionTaxExpense
51210000 usd
CY2023Q1 us-gaap Production Tax Expense
ProductionTaxExpense
34918000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11393000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13000000 usd
CY2024Q1 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
173958000 usd
CY2023Q1 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
94618000 usd
CY2024Q1 us-gaap Other Expenses
OtherExpenses
2019000 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
1001000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
344027000 usd
CY2023Q1 us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
460982000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
221625000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
52321000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
360589000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
37925000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
30143000 usd
CY2024Q1 nog Derivative Gain Loss On Derivative Net Unsettled Interest Rate Derivative
DerivativeGainLossOnDerivativeNetUnsettledInterestRateDerivative
0 usd
CY2023Q1 nog Derivative Gain Loss On Derivative Net Unsettled Interest Rate Derivative
DerivativeGainLossOnDerivativeNetUnsettledInterestRateDerivative
-1017000 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
0 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
659000 usd
CY2024Q1 nog Gain Loss On Contingent Consideration
GainLossOnContingentConsideration
0 usd
CY2023Q1 nog Gain Loss On Contingent Consideration
GainLossOnContingentConsideration
6176000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
56000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4619000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37869000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19706000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14452000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
340883000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2846000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
692000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
11606000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
340191000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.98
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100442472 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84915729 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101636132 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85407197 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
11606000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
340191000 usd
CY2024Q1 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
173958000 usd
CY2023Q1 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
94618000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2203000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1751000 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-284000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-510000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2760000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
692000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-157648000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
138970000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2274000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2151000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2316000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3084000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-39719000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2866000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
78000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
314000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2641000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11903000 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1793000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-8915000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4409000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2866000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
392147000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
269308000 usd
CY2024Q1 us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
407006000 usd
CY2024Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
50000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
238000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-407056000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-461220000 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
180000000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
337000000 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
78000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
87000000 usd
CY2024Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
0 usd
CY2023Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
18436000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
32000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20007000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8004000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2712000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2616000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
40099000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
25454000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39183000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
195458000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24273000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3545000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8195000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2528000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32468000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6073000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2047676000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2296000 usd
CY2024Q1 nog Stock Issued During Period Value Restricted Stock Award Surrenders Tax Obligations
StockIssuedDuringPeriodValueRestrictedStockAwardSurrendersTaxObligations
2712000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
3737000 usd
CY2024Q1 nog Stock Issued During Period Value Warrants Issued
StockIssuedDuringPeriodValueWarrantsIssued
0 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
20207000 usd
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
40418000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
11606000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2001980000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
745260000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
54000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2316000 usd
CY2023Q1 nog Stock Issued During Period Value Restricted Stock Award Surrenders Tax Obligations
StockIssuedDuringPeriodValueRestrictedStockAwardSurrendersTaxObligations
2616000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
8004000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
29026000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
340191000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1048067000 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
ORGANIZATION AND NATURE OF BUSINESS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Northern Oil and Gas, Inc. (the “Company,” “Northern,” “our” and words of similar import), a Delaware corporation, is an independent energy company engaged in the acquisition, exploration, development and production of oil and natural gas properties in the United States, primarily in the Williston Basin, the Permian Basin and the Appalachian Basin. The Company’s common stock trades on the New York Stock Exchange under the symbol “NOG”.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s principal business is crude oil and natural gas exploration, development, and production with operations in the United States. The Company’s primary strategy is investing in non-operated minority working and mineral interests in oil and gas properties, with a core area of focus in three premier basins within the United States.</span></div>
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements under GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant estimates relate to proved crude oil and natural gas reserves, which includes limited control over future development plans as a non-operator, estimates relating to certain crude oil and natural gas revenues and expenses, fair value of derivative instruments, fair value of contingent consideration, acquisition date fair values of assets acquired and liabilities assumed, impairment of crude oil and natural gas properties, asset retirement obligations and deferred income taxes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management’s estimates and assumptions were based on historical data and consideration of future market conditions. Given the uncertainty inherent in any projection, actual results may differ from the estimates and assumptions used, and conditions may change, which could materially affect amounts reported in the unaudited condensed financial statements.</span></div>
CY2024Q1 nog Revenuefrom Contractwith Customer Numberof Revenue Sources
RevenuefromContractwithCustomerNumberofRevenueSources
2 revenuesource
CY2024Q1 nog Numberof Geographic Areasinwhich Entity Operates
NumberofGeographicAreasinwhichEntityOperates
3 geographicarea
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Concentrations of Market, Credit Risk and Other Risks</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The future results of the Company’s crude oil and natural gas operations will be affected by the market prices of crude oil and natural gas.  The availability of a ready market for crude oil and natural gas products in the future will depend on numerous factors beyond the control of the Company, including weather, imports, marketing of competitive fuels, proximity and capacity of crude oil and natural gas pipelines and other transportation facilities, any oversupply or undersupply of crude oil, natural gas and liquid products, the regulatory environment, the economic environment, and other regional and political events, none of which can be predicted with certainty.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the exploration, development and production sector of the crude oil and natural gas industry.  The Company’s receivables include amounts due, indirectly via the third-party operators of the wells, from purchasers of its crude oil and natural gas production.  While certain of these customers, as well as third-party operators of the wells, are affected by periodic downturns in the economy in general or in their specific segment of the crude oil or natural gas industry, the Company believes that its level of credit-related losses due to such economic fluctuations have been immaterial.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a non-operator, 100% of the Company’s wells are operated by third-party operating partners. As a result, the Company is highly dependent on the success of these third-party operators. If they are not successful in the exploration, development and production activities relating to the Company’s leasehold interests, or are unable or unwilling to perform, the Company’s </span></div>financial condition and results of operation could be adversely affected. These risks are heightened in a low commodity price environment, which may present significant challenges to these third-party operators. The Company’s third-party operators will make decisions in connection with their operations that may not be in the Company’s best interests, and the Company may have little or no ability to exercise influence over the operational decisions of its third-party operators.<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company faces concentration risk due to the fact that substantially all of its oil and natural gas revenue is sourced from a limited number of geographic areas of operations. As a result, the Company is disproportionately exposed to risks that affect one or more of those areas in the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), and the Appalachian Basin (Ohio and Pennsylvania).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages and controls market and counterparty credit risk. In the normal course of business, collateral is not required for financial instruments with credit risk. Financial instruments which potentially subject the Company to credit risk consist principally of cash balances and derivative financial instruments. The Company maintains cash and cash equivalents in bank deposit accounts which, at times, may exceed the federally insured limits. The Company has not experienced any significant losses from such investments. The Company attempts to limit the amount of credit exposure to any one financial institution or company. The Company believes the credit quality of its counterparties is generally high. In the normal course of business, letters of credit or parent guarantees may be required for counterparties which management perceives to have a higher credit risk.</span></div>
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
11606000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
340191000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100442472 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84915729 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1193660 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
491468 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101636132 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85407197 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.98
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
35981000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
28878000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
25000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
211287000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
217065000 usd
CY2024Q1 nog Capitalized Asset Retirement Obligations
CapitalizedAssetRetirementObligations
1890000 usd
CY2023Q1 nog Capitalized Asset Retirement Obligations
CapitalizedAssetRetirementObligations
962000 usd
CY2024Q1 nog Compensation Capitalizedon Oiland Gas Properties
CompensationCapitalizedonOilandGasProperties
22000 usd
CY2023Q1 nog Compensation Capitalizedon Oiland Gas Properties
CompensationCapitalizedonOilandGasProperties
111000 usd
CY2024Q1 us-gaap Stock Issued1
StockIssued1
23338000 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
13328000 usd
CY2024Q1 nog Dividends Declared Common Stock
DividendsDeclaredCommonStock
40418000 usd
CY2023Q1 nog Dividends Declared Common Stock
DividendsDeclaredCommonStock
29021000 usd
CY2024Q1 nog Repurchase Of Stock For Excise Tax Noncash
RepurchaseOfStockForExciseTaxNoncash
200000 usd
CY2023Q1 nog Repurchase Of Stock For Excise Tax Noncash
RepurchaseOfStockForExciseTaxNoncash
0 usd
CY2024Q1 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
0 usd
CY2023Q1 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
0 usd
CY2024Q1 nog Business Combination Consideration Transferred Cash Deposit
BusinessCombinationConsiderationTransferredCashDeposit
17100000 usd
CY2024Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
399298000 usd
CY2023Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
713503000 usd
CY2024Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
11855000 usd
CY2023Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
433053000 usd
CY2024Q1 nog Anticipated Timing Of Inclusion Of Cost In Amortization Calculation
AnticipatedTimingOfInclusionOfCostInAmortizationCalculation
P5Y
CY2024Q1 nog Capitalized Costs Related To Expired Leases Subject To Depletion
CapitalizedCostsRelatedToExpiredLeasesSubjectToDepletion
1100000 usd
CY2023Q1 nog Capitalized Costs Related To Expired Leases Subject To Depletion
CapitalizedCostsRelatedToExpiredLeasesSubjectToDepletion
600000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1968108000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-1492000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
30868000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
1938731000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1866108000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-1776000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
32330000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1835554000 usd
CY2022Q4 us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
36100000 usd
CY2022Q4 nog Capped Call Transaction Common Stock Premium Over Share Price Percent
CappedCallTransactionCommonStockPremiumOverSharePricePercent
0.75
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
135000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101044071 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101044071 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000 usd
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
549356 shares
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
20200000 usd
CY2024Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
200000 usd
CY2022Q4 us-gaap Share Price
SharePrice
24.98
CY2023Q4 us-gaap Share Price
SharePrice
37.07
CY2023Q4 us-gaap Share Price
SharePrice
37.07
CY2024Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2800000 usd
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
700000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.197
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
CY2024Q1 us-gaap Costs Incurred Asset Retirement Obligation Incurred
CostsIncurredAssetRetirementObligationIncurred
1100000 usd
CY2024Q1 nog Derivative Gain Loss On Derivative Net Settled Commodity Derivatives
DerivativeGainLossOnDerivativeNetSettledCommodityDerivatives
19117000 usd
CY2023Q1 nog Derivative Gain Loss On Derivative Net Settled Commodity Derivatives
DerivativeGainLossOnDerivativeNetSettledCommodityDerivatives
13670000 usd
CY2024Q1 nog Derivative Gain Loss On Derivative Net Unsettled Commodity Derivatives
DerivativeGainLossOnDerivativeNetUnsettledCommodityDerivatives
-157648000 usd
CY2023Q1 nog Derivative Gain Loss On Derivative Net Unsettled Commodity Derivatives
DerivativeGainLossOnDerivativeNetUnsettledCommodityDerivatives
139987000 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-138531000 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
153656000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
112905000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
170029000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
306722000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
206198000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
112905000 usd
CY2024Q1 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
75125000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
37780000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
306722000 usd
CY2024Q1 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
75125000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
231597000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
170029000 usd
CY2023Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
83570000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
86459000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
206198000 usd
CY2023Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
83570000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
122628000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001104485-24-000114-index-headers.html Edgar Link pending
0001104485-24-000114-index.html Edgar Link pending
0001104485-24-000114.txt Edgar Link pending
0001104485-24-000114-xbrl.zip Edgar Link pending
exhibit101-formof3xyearrsu.htm Edgar Link pending
exhibit31120240331-10q.htm Edgar Link pending
exhibit31220240331-10q.htm Edgar Link pending
exhibit32120240331-10q.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nog-20240331.htm Edgar Link pending
nog-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
nog-20240331_cal.xml Edgar Link unprocessable
nog-20240331_def.xml Edgar Link unprocessable
nog-20240331_lab.xml Edgar Link unprocessable
nog-20240331_pre.xml Edgar Link unprocessable
nog-20240331_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable